Today's Date: May 18, 2022
Four recipients of the 2022 Awards of Excellence in Nursing announced from Indigenous Services Canada   •   Carter’s Appoints Hilary Duff as Chief Mom Officer   •   Five Bluum Standouts Honored on CRN 2022 Women of the Channel List   •   Toast Restaurant Q1 Trends Report: Dine In Growth Surges While Takeout and Delivery Decline   •   RNR Tire Express Surprises Tampa-Area Woman with New Car in Mother's Day Giveaway   •   Evolus Celebrates Third Anniversary of the Launch of Jeuveau® in the United States   •   Global Surrogacy Services Announces Outreach to Potential Gestational Surrogates in Three Southwestern States   •   Perfect Corp. Brings Paramount Pictures’ Top Gun: Maverick to Life through an Interactive AR Virtual Try-On Experience   •   Checkmarx' Ana Lucia Amaral Honored as a CRN 2022 Woman of the Channel   •   Mrs. Flowers Takes the Helm at Comfort Home Care, Rockville, MD   •   Tracey Hayes from MicroAge Named on CRN's 2022 Women of the Channel Power 70 Solution Providers List   •   NCCI Golf Event Generates $25,000 for Kids' Chance of America Scholarships   •   BeautyHealth’s HydraFacial Announces Second Annual GLOWvolution Tour   •   Wave Neuroscience, Tomahawk Charitable Solutions and Special Operations Care-Fund Announce Continuation of Partnership to Suppor   •   Closing the Health Disparity Gap for Black Women   •   Equitable Bank Releases Inaugural ESG Performance Report   •   The Gift of Fear by Gavin de Becker is Now a Master Class Series   •   Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors   •   Mastercard Economics Institute: Pent-up demand drives global leisure and business flight bookings past 2019 levels   •   Mednax Announces Leadership Appointments
Bookmark and Share

New Drugs Encouraging For Blacks Hepatitis C Patients

HOUSTON — Two new drugs just approved by the Food and Drug Administration (FDA) to treat hepatitis C genotype 1 significantly improved the cure rates of patients. One of the drugs was extremely effective in treating African Americans.

The current standard of treatment of interferon and ribavirun has only been effective in curing 38 to 40 percent of patients with chronic hepatitis C genotype 1. In clinical trials, Victrelis and Incivek, when working in concert with interferon and ribavirun, cured 65 to 75 percent of people with chronic disease and Victrelis-alone doubled the previous cure rate among African Americans. 

“African Americans represent a patient population that typically does not respond well to standard therapy,” said Dr. Howard Monsour, chief of Hepatology at The Methodist Hospital in Houston and one of the physicians involved in the clinical trials. “Victrelis has helped boost the cure rate from 23 percent to 53 percent, which is extremely encouraging.”

Monsour believes the recent approval of both drugs represents the most significant news in the fight against hepatitis C in a decade.

Hepatitis C is a viral infection that leads to inflammation of the liver. IV drug use is the most common cause and it affects nearly two percent of the U.S. population. Some 80 percent of people with hepatitis C develop chronic disease and between 20 and 50 percent will develop cirrhosis of the liver.

Victrelis and Incivek work effectively by attacking the virus directly and interfering with the virus’ ability to replicate. They are only effective against a genotype 1 infection, which is most common form of hepatitis C in the United States.

The clinical trials studied three classes of patients: 1) Patients who had never been treated. 2) Patients who had been treated, lost the virus, but had a relapse once the medication stopped. 3) Patients who responded poorly to treatment without the loss of the virus.

“We found a 65 to 75 percent cure rate in both the people who had never been treated and in those who had a relapse and in the third group we found up to a 55 percent cure rate,” Monsour said. “The drugs have also shortened the treatment time from a year to, in most cases, six to eight months, and with many other drugs in development, the future looks very bright.”


STORY TAGS: Hepatitis CBlack News, African American News, Minority News, Civil Rights News, Discrimination, Racism, Racial Equality, Bias, Equality, Afro American News



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News